3 Automotive Technology Company, Contract Drug Manufacturer and Defence Shipbuilder Stocks With a Strong Future Roadmap: Bosch, Innova Captab and Mazagon Dock Shipbuilders
- November 19, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Bosch, Innova Captab and Mazagon Dock Shipbuilders: ROE of 12.9% to 26.5% and FY22 to FY26 revenue CAGR of 14.5% to 23.2%. Prices as of 18 Nov 2026.
Quick Answer
The three spark plug, contract drug and navy ship stocks to watch are Bosch, Innova Captab and Mazagon Dock Shipbuilders. Their return on equity ranges from 12.9% to 26.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.5% to 23.2%. Mazagon Dock Shipbuilders leads on both return on equity at 26.5% and revenue growth at 23.2% a year. Prices are based on the 18 November 2026 close, and this article is educational, not investment advice.
Spark plug, contract drug and navy ship stocks let investors follow companies that serve a growing part of the Indian economy. Bosch, Innova Captab and Mazagon Dock Shipbuilders cover an automotive technology company, a contract drug manufacturer and a defence shipbuilder.
This list covers three spark plug, contract drug and navy ship stocks with complete current figures: Bosch, Innova Captab and Mazagon Dock Shipbuilders. Every figure comes from the latest reported financials and the 18 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Spark Plug, Contract Drug and Navy Ship Stocks?
Spark plug, contract drug and navy ship stocks are listed companies that make fuel injection, spark plugs and automotive electronics, make medicines and drug ingredients for other drug makers, and build warships and submarines for the navy. Their earnings depend on vehicle output, outsourcing orders and defence orders.
Spark Plug, Contract Drug and Navy Ship Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Bosch | 49,170 | 130,794 | 55.4 | 36.1 | 15.8 | 0.01 |
| Innova Captab | 1,050.1 | 5,736 | 37.2 | 36.0 | 12.9 | 0.32 |
| Mazagon Dock Shipbuilders | 1,822.4 | 82,854 | 29.0 | 48.1 | 26.5 | 0.05 |
On valuation, Mazagon Dock Shipbuilders trades at a P/E below the industry P/E, while Bosch and Innova Captab trade above it, which reflects the growth the market already expects. Readers comparing spark plug, contract drug and navy ship stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in spark plug, contract drug and navy ship stocks can use the coming numbers to test whether growth is holding.
Why Do Spark Plug, Contract Drug and Navy Ship Stocks Have a Strong Roadmap in India?
Spark plug, contract drug and navy ship stocks have a strong roadmap in India because steady vehicle output, rising outsourcing of drug making and a long pipeline of naval orders keep widening the market for these companies.
- Automotive technology. New vehicles carry advanced electronics.
- Contract manufacturing. Drug makers outsource production.
- Naval shipbuilding. The navy orders new ships and submarines.
Why Bosch Features Among These Spark Plug, Contract Drug and Navy Ship Stocks
Among the spark plug, contract drug and navy ship stocks on this list, Bosch is a leading automotive supplier in India with powertrain and mobility solutions, aftermarket parts and a growing range of industrial and building technology offerings.
In the June 2026 quarter, revenue grew 19.5% year on year to Rs 6,068 crore. Revenue rose from Rs 12,172 crore in FY22 to Rs 20,889 crore in FY26, a compound annual growth rate of 14.5%.
Net profit grew from Rs 1,217 crore in FY22 to Rs 2,770 crore in FY26, which works out to a compound annual growth rate of 22.8%. The company has a return on equity of 15.8%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 130,794 crore. The stock trades at a P/E of 55.4, above the industry P/E of 36.1.
Roadmap: The company benefits from rising vehicle content, stricter emission rules and demand for electrification and connected technology. A strong aftermarket network and a trusted brand support steady revenue.
What to watch: Track the mix of mobility and aftermarket revenue and progress in electrification products.
Why Innova Captab Features Among These Spark Plug, Contract Drug and Navy Ship Stocks
Among the auto electronics, outsourced pharma and warship builder shares on this list, Innova Captab is a Himachal Pradesh-based pharmaceutical company that makes formulations for other pharma companies, manufactures its own branded generics and supplies active ingredients.
The company has a return on equity of 12.9%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 5,736 crore. The stock trades at a P/E of 37.2, above the industry P/E of 36.0.
Revenue rose from Rs 803 crore in FY22 to Rs 1,637 crore in FY26, a compound annual growth rate of 19.5%. Net profit grew from Rs 64.0 crore in FY22 to Rs 141 crore in FY26, which works out to a compound annual growth rate of 21.8%. In the June 2026 quarter, revenue grew 32.8% year on year to Rs 473 crore, while net profit rose 42.3% to Rs 44.1 crore.
Roadmap: The company combines contract manufacturing with its own branded generics business, which lets it capture more of the value chain. It has also been expanding capacity and widening its customer base.
What to watch: Watch the growth in the branded business and the utilisation of expanded capacity.
Why Mazagon Dock Shipbuilders Features Among These Spark Plug, Contract Drug and Navy Ship Stocks
Among the three companies on this list, Mazagon Dock Shipbuilders is a Mumbai-based defence shipyard that builds warships and submarines for the Indian Navy and also takes on ship repair and offshore work.
Revenue rose from Rs 6,144 crore in FY22 to Rs 14,146 crore in FY26, a compound annual growth rate of 23.2%. Net profit grew from Rs 563 crore in FY22 to Rs 2,422 crore in FY26, which works out to a compound annual growth rate of 44.0%.
In the June 2026 quarter, revenue grew 10.4% year on year to Rs 3,256 crore, while net profit rose 22.1% to Rs 512 crore. The company has a return on equity of 26.5%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 82,854 crore. The stock trades at a P/E of 29.0, below the industry P/E of 48.1.
Roadmap: The shipyard has a long order book of destroyers, frigates and submarines, and the multi-year build cycle gives revenue visibility. Capacity additions and a push towards indigenous submarine and warship programmes support its position as a core naval supplier.
What to watch: Monitor milestone-linked revenue on the big naval programmes and any fresh orders announced through the year.
Bosch vs Innova Captab vs Mazagon Dock Shipbuilders on Key Financials
The table below sets the three spark plug, contract drug and navy ship stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Bosch | 12,172 | 20,889 | 14.5% | 2,770 | 13.3% |
| Innova Captab | 803 | 1,637 | 19.5% | 141 | 8.6% |
| Mazagon Dock Shipbuilders | 6,144 | 14,146 | 23.2% | 2,422 | 17.1% |
Mazagon Dock Shipbuilders posts the highest return on equity in this group at 26.5%. Bosch has the largest FY26 revenue at Rs 20,889 crore, and Mazagon Dock Shipbuilders shows the fastest revenue growth with a 23.2% compound annual rate. A useful habit with spark plug, contract drug and navy ship stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several automotive technology, contract manufacturing and defence shipbuilding stocks instead of one name, which keeps a single result from deciding the outcome.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Bosch | 5,077 | 6,068 | 19.5% |
| Innova Captab | 356 | 473 | 32.8% |
| Mazagon Dock Shipbuilders | 2,949 | 3,256 | 10.4% |
Key Risks to Check Before Investing in Spark Plug, Contract Drug and Navy Ship Stocks
Every theme carries risks that deserve a check before any decision. For these spark plug, contract drug and navy ship stocks, the main points are: Long-term auto electronics, outsourced pharma and warship builder shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Demand cycles. Sales can vary with seasons and rates.
- Order timing. Project awards can shift between periods.
- Order timing. Defence and space orders can shift between periods.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter spark plug, contract drug and navy ship stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Spark Plug, Contract Drug and Navy Ship Stocks
Spark plug, contract drug and navy ship stocks reward investors who follow demand trends, order books and margins together. Bosch, Innova Captab and Mazagon Dock Shipbuilders each have a clear plan to grow. Based on the 18 November 2026 close, Bosch trades at Rs 49,170, Innova Captab at Rs 1,050.1 and Mazagon Dock Shipbuilders at Rs 1,822.4. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these spark plug, contract drug and navy ship stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track spark plug, contract drug and navy ship stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are spark plug, contract drug and navy ship stocks?
Ans. Spark plug, contract drug and navy ship stocks are listed companies that make fuel injection, spark plugs and automotive electronics, make medicines and drug ingredients for other drug makers, and build warships and submarines for the navy. Their earnings depend on vehicle output, outsourcing orders and defence orders. This list looks at three of them, Bosch, Innova Captab and Mazagon Dock Shipbuilders, using reported FY22 to FY26 financials and the 18 November 2026 closing prices.
Which spark plug, contract drug and navy ship stocks are covered in this list?
Ans. This list covers Bosch, Innova Captab and Mazagon Dock Shipbuilders. Based on the 18 November 2026 close, Bosch traded at Rs 49,170, Innova Captab at Rs 1,050.1 and Mazagon Dock Shipbuilders at Rs 1,822.4. Their return on equity ranges from 12.9% to 26.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.5% to 23.2%.
Why do spark plug, contract drug and navy ship stocks have a strong future roadmap in India?
Ans. Spark plug, contract drug and navy ship stocks have a strong roadmap in India because steady vehicle output, rising outsourcing of drug making and a long pipeline of naval orders keep widening the market for these companies. The main drivers are as follows. Automotive technology. New vehicles carry advanced electronics. Contract manufacturing. Drug makers outsource production. Naval shipbuilding. The navy orders new ships and submarines. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Bosch performed financially?
Ans. Revenue rose from Rs 12,172 crore in FY22 to Rs 20,889 crore in FY26, a compound annual growth rate of 14.5%. Net profit grew from Rs 1,217 crore in FY22 to Rs 2,770 crore in FY26, which works out to a compound annual growth rate of 22.8%. In the June 2026 quarter, revenue grew 19.5% year on year to Rs 6,068 crore. The company has a return on equity of 15.8%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 130,794 crore. The stock trades at a P/E of 55.4, above the industry P/E of 36.1. Looking ahead, the company benefits from rising vehicle content, stricter emission rules and demand for electrification and connected technology. A strong aftermarket network and a trusted brand support steady revenue.
How has Innova Captab performed financially?
Ans. Revenue rose from Rs 803 crore in FY22 to Rs 1,637 crore in FY26, a compound annual growth rate of 19.5%. Net profit grew from Rs 64.0 crore in FY22 to Rs 141 crore in FY26, which works out to a compound annual growth rate of 21.8%. In the June 2026 quarter, revenue grew 32.8% year on year to Rs 473 crore, while net profit rose 42.3% to Rs 44.1 crore. The company has a return on equity of 12.9%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 5,736 crore. The stock trades at a P/E of 37.2, above the industry P/E of 36.0. Looking ahead, the company combines contract manufacturing with its own branded generics business, which lets it capture more of the value chain. It has also been expanding capacity and widening its customer base.
How has Mazagon Dock Shipbuilders performed financially?
Ans. Revenue rose from Rs 6,144 crore in FY22 to Rs 14,146 crore in FY26, a compound annual growth rate of 23.2%. Net profit grew from Rs 563 crore in FY22 to Rs 2,422 crore in FY26, which works out to a compound annual growth rate of 44.0%. In the June 2026 quarter, revenue grew 10.4% year on year to Rs 3,256 crore, while net profit rose 22.1% to Rs 512 crore. The company has a return on equity of 26.5%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 82,854 crore. The stock trades at a P/E of 29.0, below the industry P/E of 48.1. Looking ahead, the shipyard has a long order book of destroyers, frigates and submarines, and the multi-year build cycle gives revenue visibility. Capacity additions and a push towards indigenous submarine and warship programmes support its position as a core naval supplier.
What risks should investors check before buying spark plug, contract drug and navy ship stocks?
Ans. Investors should check a few risks before buying spark plug, contract drug and navy ship stocks. Demand cycles. Sales can vary with seasons and rates. Order timing. Project awards can shift between periods. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of spark plug, contract drug and navy ship stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 18 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.